These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8687100)

  • 1. Induction of cell death by Doxorubicin in multicellular spheroids as studied by confocal laser scanning microscopy.
    Wartenberg M; Acker H
    Anticancer Res; 1996; 16(2):573-9. PubMed ID: 8687100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin distribution in multicellular prostate cancer spheroids evaluated by confocal laser scanning microscopy and the "optical probe technique".
    Wartenberg M; Hescheler J; Acker H; Diedershagen H; Sauer H
    Cytometry; 1998 Feb; 31(2):137-45. PubMed ID: 9482283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles.
    Kim TH; Mount CW; Gombotz WR; Pun SH
    Biomaterials; 2010 Oct; 31(28):7386-97. PubMed ID: 20598741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an intrinsic P-glycoprotein-mediated doxorubicin resistance in quiescent cell layers of large, multicellular prostate tumor spheroids.
    Wartenberg M; Frey C; Diedershagen H; Ritgen J; Hescheler J; Sauer H
    Int J Cancer; 1998 Mar; 75(6):855-63. PubMed ID: 9506530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
    Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and characterization of LNCaP prostate cancer cell spheroids.
    Ballangrud AM; Yang WH; Dnistrian A; Lampen NM; Sgouros G
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3171s-3176s. PubMed ID: 10541360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
    Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
    Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
    Lee SY; Jeong EK; Jeon HM; Kim CH; Kang HS
    Oncol Rep; 2010 Jul; 24(1):73-9. PubMed ID: 20514446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive intracellular accumulation of ID-6105, a novel anthracycline, in SK-OV-3 ovarian cancer cells.
    Shin DH; Choi KS; Park SA; Cho BS; Lee HS; Ryu JS; Kim TY; Lee CK; Song S; Chung YB
    Arch Pharm Res; 2008 Oct; 31(10):1355-61. PubMed ID: 18958428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing.
    Zhang X; Wang W; Yu W; Xie Y; Zhang X; Zhang Y; Ma X
    Biotechnol Prog; 2005; 21(4):1289-96. PubMed ID: 16080713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of laser-ICG photothermotherapy and doxorubicin chemotherapy on ovarian cancer cells.
    Tang Y; McGoron AJ
    J Photochem Photobiol B; 2009 Dec; 97(3):138-44. PubMed ID: 19811928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative recording of vitality patterns in living multicellular spheroids by confocal microscopy.
    Wartenberg M; Acker H
    Micron; 1995; 26(5):395-404. PubMed ID: 8640359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q
    Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of doxorubicin with the subcellular structures of the sensitive and Bcl-xL-overexpressing MCF-7 cell line: confocal and low-energy-loss transmission electron microscopy.
    Mhawi AA
    Micron; 2009 Oct; 40(7):702-12. PubMed ID: 19502069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet-based microfluidic system for multicellular tumor spheroid formation and anticancer drug testing.
    Yu L; Chen MC; Cheung KC
    Lab Chip; 2010 Sep; 10(18):2424-32. PubMed ID: 20694216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles.
    Wang X; Zhen X; Wang J; Zhang J; Wu W; Jiang X
    Biomaterials; 2013 Jun; 34(19):4667-79. PubMed ID: 23537667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer.
    Houba PH; Boven E; van der Meulen-Muileman IH; Leenders RG; Scheeren JW; Pinedo HM; Haisma HJ
    Br J Cancer; 2001 Feb; 84(4):550-7. PubMed ID: 11207053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.